The story has been updated to include comments from Qiagen's conference call.

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Monday that its revenues rose 2 percent year over year as growth in molecular diagnostics and applied testing offset weakness in pharma and academia.

Separately, Qiagen said that it acquired genomic data software firm Ingenuity Systems for $105 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.